These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9543566)

  • 1. Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.
    Erlacher L; Wyatt J; Pflugbeil S; Köller M; Ullrich R; Vogelsang H; Smolen JS; Graninger W
    Clin Exp Rheumatol; 1998; 16(1):69-71. PubMed ID: 9543566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
    Caunedo-Alvarez A; Gómez-Rodríguez BJ; Romero-Vázquez J; Argüelles-Arias F; Romero-Castro R; García-Montes JM; Pellicer-Bautista FJ; Herrerías-Gutiérrez JM
    Rev Esp Enferm Dig; 2010 Feb; 102(2):80-5. PubMed ID: 20361843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive detection of nonsteroidal anti-inflammatory drug-induced gastropathy in dogs.
    Meddings JB; Kirk D; Olson ME
    Am J Vet Res; 1995 Aug; 56(8):977-81. PubMed ID: 8533987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucrose: a novel permeability marker for gastroduodenal disease.
    Meddings JB; Sutherland LR; Byles NI; Wallace JL
    Gastroenterology; 1993 Jun; 104(6):1619-26. PubMed ID: 8500718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucrose permeability as a marker for nonsteroidal anti-inflammatory gastroduodenal injury: how sweet is it?
    DeMeo M
    Nutr Rev; 1995 Jan; 53(1):13-6. PubMed ID: 7885621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical management of NSAID gastropathy in rheumatic patients.
    Peltier AP
    Scand J Rheumatol Suppl; 1989; 78():12-7; discussion 30-2. PubMed ID: 2786645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy.
    Jaszewski R
    J Clin Gastroenterol; 1990 Feb; 12(1):10-3. PubMed ID: 2303676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual gastrointestinal manifestation of non-steroidal anti-inflammatory drugs.
    Kekilli M; Köklü S; Beyazit Y; Arhan M; Basar O
    Dig Endosc; 2010 Jul; 22(3):251-2. PubMed ID: 20642623
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury.
    Lai LH; Chan FK
    Curr Opin Gastroenterol; 2009 Nov; 25(6):544-8. PubMed ID: 19696667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual analogue scales for endoscopic evaluation of nonsteroidal anti-inflammatory drug-induced mucosal damage in the stomach and duodenum.
    Aabakken L; Larsen S; Osnes M
    Scand J Gastroenterol; 1990 May; 25(5):443-8. PubMed ID: 2193376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid therapy augments gastroduodenal permeability to sucrose.
    Kiziltaş S; Imeryüz N; Gürcan T; Siva A; Saip S; Dumankar A; Kalayci C; Ulusoy NB
    Am J Gastroenterol; 1998 Dec; 93(12):2420-5. PubMed ID: 9860402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAID-associated gastroduodenal damage: does famotidine protection extend into the mid- and distal duodenum?
    Aabakken L; Bjørnbeth BA; Weberg R; Viksmoen L; Larsen S; Osnes M
    Aliment Pharmacol Ther; 1990 Jun; 4(3):295-303. PubMed ID: 2129490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of NSAID-induced gastroduodenal complications.
    Hiele M
    Clin Rheumatol; 1996 Sep; 15(5):431-4. PubMed ID: 8894354
    [No Abstract]   [Full Text] [Related]  

  • 16. [An open study on the efficacy and safety of misoprostol in prevention or treatment of gastroduodenal lesions induced by NSAID: preliminary data].
    Passiu G
    Clin Ter; 1991 Dec 15-31; 139(5-6):191-2. PubMed ID: 1802506
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulations.
    Zuin M; Podda M; Selmi C; Giorgini A; Zermiani P; Mandelli G; Sacchetta AC; Candiani C
    Arzneimittelforschung; 2000 Sep; 50(9):837-42. PubMed ID: 11050702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of gastrointestinal toxicity of ibuprofen using surrogate markers in rats: effect of formulation and route of administration.
    Khazaeinia T; Jamali F
    Clin Exp Rheumatol; 2000; 18(2):187-92. PubMed ID: 10812490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and NSAID induced gastropathy.
    Zeidler H
    J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic therapy with non-steroidal antiinflammatory drugs on gastric permeability of sucrose: a study on 71 patients with rheumatoid arthritis.
    Maino M; Mantovani N; Merli R; Cavestro GM; Leandro G; Cavallaro LG; Corrente V; Iori V; Pilotto A; Franzè A; Di Mario F
    World J Gastroenterol; 2006 Aug; 12(31):5017-20. PubMed ID: 16937498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.